医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AstraZeneca Chooses Box to Power Enterprise Content Collaboration for All Employees

2015年01月28日 AM12:00
このエントリーをはてなブックマークに追加


 

LOS ALTOS, Calif. & LONDON

Box today announced that AstraZeneca, a global, innovation-driven biopharmaceutical business, is making Box’s cloud content sharing and collaboration platform available to its 51,000 employees across more than 100 countries. AstraZeneca chose Box to power secure collaboration company-wide and with external parties, as well as to enable mobile access to information.

“Technology is a key driver of innovation at AstraZeneca, and collaboration and mobility are two initiatives at the forefront of our strategy,” said David Smoley, CIO at AstraZeneca. “Box has become the industry standard in this space and we’ve chosen it to continue our drive toward efficiency, security and simplicity for all our employees.”

“AstraZeneca’s move to Box follows our deep emphasis on life sciences, which is an important sector for us,” said David Quantrell, Box senior vice president and general manager of EMEA. “Box helps customers in this vertical, like AstraZeneca, confidently embrace collaboration and mobility by coupling an intuitive end-user experience with robust admin controls to securely manage information at scale.”

AstraZeneca focuses on creating environments that enable productivity through secure, user-friendly tools. Its deployment of new collaborative technology is part of the company’s larger strategy to be an innovative leader in the pharmaceutical space. AstraZeneca has also agreed to join a Box customer advisory board designed to guide new technology development and consistently improve the service to Box users.

Box makes it easy for more than 32 million individuals at 275,000 businesses around the world to share and collaborate. With today’s announcement, AstraZeneca joins a growing list of global leaders who have moved to Box, including BG Group, General Electric, Anglo American, and Schneider Electric.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.

About Box

Founded in 2005, Box (NYSE:BOX) is transforming the way people and organizations work so they can achieve their greatest ambitions. As the world’s leading enterprise software platform for content collaboration, Box helps business of all sizes in every industry securely access and manage their critical information in the cloud. Box is headquartered in Los Altos, CA, with offices across the United States, Europe and Asia. To learn more about Box, visit www.box.com.

CONTACT

Box PR
Titus Thomson, 44 (0) 2036919586
titus@box.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent